Bending Spoons Is Now Public. The Story Has 1,000 Chapters Left.
An Italian software roll-up just had one of the year's best IPO debuts.
An Italian software roll-up just had one of the year's best IPO debuts.
Record revenue, 85% growth, and a raised outlook — yet the stock keeps sliding.
The world's No. 2 container carrier upgraded EBITDA and EBIT guidance today, and the reason matters for more than shipping…
The biggest structural shift in corporate credit in decades is happening in plain sight.
Manufacturing just hit a 4-year high. The S&P 500 barely noticed.
XLV is leading, but not every part of healthcare is going the same direction.
Four years of trucking pain may be ending. The pricing cycle that follows could be sharper than anyone expects.
A kidney disease drug with Breakthrough Therapy status is 11 days from an FDA decision.
A $40B non-handset target, a Meta deal, and a data center chip that changes everything.
A $54.6 billion autonomous warfare budget is being built in real time. The stocks are off 50%+ from their highs.